Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
46%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
28%
ALSO IN FTXH
FTXH
51
HOLDINGS
34%
ALSO IN XLV
SECTOR DRIFT (XLV minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 8.2% | 8.2% |
|
ABBVIE INC | 7.8% | 7.7% | 7.7% |
|
JOHNSON & JOHNSON | 9.8% | 6.9% | 6.9% |
|
MERCK & CO. INC. | 5.5% | 6.8% | 5.5% |
|
AMGEN INC | 3.8% | 3.6% | 3.6% |
XLV Overweight Relative to FTXH
|
ELI LILLY & CO | 8.7% |
|
UNITEDHEALTH GROUP INC | 5.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
JOHNSON & JOHNSON | 2.9% |
|
ABBOTT LABORATORIES | 2.7% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
DANAHER CORP | 2.2% |
 |
MEDTRONIC PLC | 1.8% |
|
MCKESSON CORP | 1.7% |
|
CVS CAREMARK CORP | 1.7% |
XLV Underweight Relative to FTXH
|
PFIZER INC | -4.6% |
|
VIATRIS, INC. | -3.5% |
|
UNITED THERAPEUTICS CORP | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
ZOETIS INC | -3.0% |
|
INCYTE CORP | -2.9% |
|
EXELIXIS INC | -2.6% |
|
REGENERON PHARMACEUTICALS | -2.5% |
|
JAZZ PHARMACEUTICALS PLC | -2.3% |
|
HALOZYME THERAPEUTICS INC | -1.8% |